Needs to stabilize! - Director Organon Employee Review

2.0
Oct 26, 2025
Recommend
CEO approval
Business Outlook

Pros

Decent pay. Nice office. Flexible work arrangements.

Cons

Unclear direction. CEO hit expiry date. Tanked the stock. Got ripped off by McKinsey. removed layers, only to add them back up, but only in R&D.

Explore other reviews about Organon

5.0
Jul 15, 2026
Recommend
CEO approval
Business Outlook

Pros

Good WLB. Very team oriented.

Cons

Raise is pretty low. Given the lack of pipeline and R&D capabilities, the team is not sure about the future for the company.

2.0
Jul 5, 2026
Anonymous employee
Recommend
CEO approval
Business Outlook

Pros

Decent compensation and work/life balance.

Cons

Company had great potential after spinoff, but was run to the ground by leadership incompetence.

See reviews by: Helpful|Rating|Date|All